(株)ヘリオスの貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4593/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2020/05/29日証協無担保600株+100%0株0%2,000株+300%
2020/05/29日証協有担保49,600株-91.94%95,599株+677.35%31,300株-87.98%
2020/05/22日証協無担保300株0%0株0%500株-61.54%
2020/05/22日証協有担保615,500株+1037.69%12,298株-86.68%260,500株+999.16%
2020/05/15日証協無担保300株+200%0株0%1,300株-50%
2020/05/15日証協有担保54,101株+486.72%92,299株-16.85%23,700株+146.88%
2020/05/08日証協無担保100株0%0株0%2,600株-60%
2020/05/08日証協有担保9,221株-89.53%110,999株+3.74%9,600株-92.86%
2020/05/01日証協無担保100株0%0株0%6,500株+20.37%
2020/05/01日証協有担保88,100株-36.66%106,999株+311.55%134,474株-36.03%
2020/04/24日証協無担保0株-100%0株0%5,400株-48.67%
2020/04/24日証協有担保139,100株-96.48%25,999株-34.18%210,200株-11.16%
2020/04/17日証協無担保900株-25%0株0%10,520株+209.41%
2020/04/17日証協有担保3,956,099株+9.86%39,498株-63.39%236,600株+217.26%
2020/04/10日証協無担保1,200株+100%0株0%3,400株-72.58%
2020/04/10日証協有担保3,600,895株-49.94%107,899株+467.11%74,576株-79.57%
2020/04/03日証協無担保600株-25%0株0%12,400株-18.96%
2020/04/03日証協有担保7,193,598株+3315.76%19,026株-93.7%365,083株+71.24%
2020/03/27日証協無担保800株+100%0株0%15,301株+66.32%
2020/03/27日証協有担保210,600株-60.91%301,955株+5598.34%213,200株-35.02%
2020/03/19日証協無担保400株+100%0株0%9,200株+282.54%
2020/03/19日証協有担保538,800株+305.72%5,299株-97.79%328,100株+211%
2020/03/13日証協無担保200株0%0株0%2,405株+381%
2020/03/13日証協有担保132,800株-96.28%239,399株+241.03%105,500株+60.73%
2020/03/06日証協無担保0株-100%0株0%500株-58.37%
2020/03/06日証協有担保3,566,058株-49.32%70,199株+214.79%65,639株+32.21%
2020/02/28日証協無担保800株-33.33%0株0%1,201株-85.87%
2020/02/28日証協有担保7,036,590株+980.06%22,300株-56.27%49,648株-64.6%
2020/02/21日証協無担保1,200株0%0株0%8,500株+2025%
2020/02/21日証協有担保651,502株-81.68%51,000株+589.19%140,259株+240.1%
2020/02/14日証協無担保0株-100%0株0%400株-50%
2020/02/14日証協有担保3,557,025株+1327.47%7,400株-90.4%41,241株-69.53%
2020/02/07日証協無担保800株+60%0株0%800株-91.11%
2020/02/07日証協有担保249,183株+426.08%77,100株+27.86%135,341株+544.48%
2020/01/31日証協無担保500株-50%0株0%9,000株+260%
2020/01/31日証協有担保47,366株-91.15%60,299株+9999.99%21,000株-56.25%
2020/01/24日証協無担保1,000株+66.67%0株0%2,500株-60.94%
2020/01/24日証協有担保535,360株+338.09%100株-99.74%48,000株-32.2%

※株式分割は考慮していませんのでご注意ください。

Page Top